[En tête-à-tête avec]
Olivier Saut, un #mathématicien qui travaille sur le #cancer !
Directeur de recherche au @CNRS et Responsable de l'équipe @MoncTeam, il travaille sur la modélisation et l’IA en #oncologie pour aider à la prise en charge des #cancers.
https://t.co/idDPNQPEtC
Open postdoc position under my supervision for quantitative modeling of response to #immunotherapy in lung cancer using a large data set with high-dimensional, longitudinal data from the #PIONeeR clinical study.
https://t.co/UcUjt4TEQb
For prediction, the mechanistic model revealed as good (if not better) than classical machine learning algorithms and Cox regression. Importantly, the MM could inform on the biological meaning of covariates (i.e. Ki67 on growth, EGFR on dissemination)
Leveraging a database with 21 clinicopathologic variables in 642 patients with no adjuvant treatment, we used random survival forest algorithms to select the set of most informative features (Ki67, tumor size, age, EGFR and CD44)
New preprint using an integrative approach to identify molecular determinants of metastasis in kidney cancer. Used lots of -omics analysis and #mathonco modeling of MRI data. Huge work led by @AndreasBikfalvi. @MoncTeam
https://t.co/2taDP7kRYk
Postdoc position available in my group about mathematical modeling of the biology of metastasis in kidney cancer from functional, imaging and genomics data. Please contact me if interested: https://t.co/ienk3DIOiS
We’re hiring! Two post-doc positions - on modeling and AI against glioma - are already available and more to come in @MoncTeam at @Inria_Bordeaux https://t.co/gF4OyyqpCX https://t.co/3oUFDjdQKF
A midi ce mercredi 15.05, rdv à l'amphithéâtre de l'Institut de mathématiques de @univbordeaux A33 pour le cycle de sémainaire de l'#oncosphère avec @AndreasBikfalvi et V.Vendrely.
Retransmission en direct sur https://t.co/mmldtMKvra
L’équipe MONC (Inria Bx @CNRS@BordeauxINP) et @SOPHiAGENETICS, permettront, grâce à de nouveaux modèles mathématiques et au #MachineLearning, de mieux appréhender le suivi patients et de définir les stratégies thérapeutiques les + adaptées.
via @INRIA https://t.co/TFTAnOyPsY